A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• The orphan receptor tyrosine kinase ErbB2 plays a crucial role in cell signaling, but its activation mechanism is unclear due to challenges in monitoring dynamic membrane receptor interactions.
• Understanding ErbB2 interactions is vital for developing targeted cancer therapies.

Purpose of the Study:

• To develop and apply a novel system for quantitatively monitoring protein-protein interactions in intact mammalian cells.
• To elucidate the interaction mechanisms of the Epidermal Growth Factor Receptor (EGFR) family, focusing on ErbB2.

Main Methods:

• Engineered a system to monitor protein-protein interactions in live mammalian cells.
• Quantitatively compared different sets of protein interactions within the EGFR family.
• Assessed the effect of the anti-cancer antibody Herceptin on EGFR and ErbB2 interactions.

Main Results:

• ErbB2 forms stable interactions with EGFR and ErbB3 but does not spontaneously homooligomerize.
• Herceptin effectively inhibits EGFR-ErbB2 interaction but not ErbB2-ErbB3 interaction.
• Herceptin treatment leads to increased EGFR homooligomerization and subsequent EGFR internalization and down-regulation in cells expressing EGFR and ErbB2.

Conclusions:

• The developed protein interaction system allows for characterization of ErbB2 interactions in their native plasma membrane environment.
• Provides novel insights into the mechanism of action of Herceptin in ErbB2-overexpressing cells.
• Highlights the differential interaction dynamics within the EGFR family and the impact of therapeutic antibodies.